- Featured Product
- KD/KO Validated
EGFR-Specific Polyclonal antibody
EGFR-Specific Polyclonal Antibody for FC, IP, WB, ELISA
Cat no : 18986-1-AP
|Positive WB detected in||L02 cells, multi-cells, HeLa/RPE1 cells, NCI-H1299 cells, HeLa cells, HepG2 cells, MCF-7 cells, A431 cells|
|Positive IP detected in||MCF-7 cells|
|Positive FC detected in||A431 cells|
|Western Blot (WB)||WB : 1:2000-1:8000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Sample-dependent, check data in validation data gallery|
18986-1-AP targets EGFR-Specific in WB, IP, IHC, IF, FC, ELISA applications and shows reactivity with human, rat samples.
|Tested Reactivity||human, rat|
|Cited Reactivity||human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Full Name||epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)|
|Calculated molecular weight||134 kDa|
|Observed molecular weight||145-165 kDa|
|GenBank accession number||NM_005228|
|Gene ID (NCBI)||1956|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
ERBB1, also mamed as EGFR, is a receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. ERBB1 is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with C-SRC and CTNNB1/beta-catenin. Isoform 2/truncated isoform of ERBB1 may act as an antagonist. EGFR is associated with lung cancer. The antibody is specific to isoform1.
|Product Specific Protocols|
|WB protocol for EGFR-Specific antibody 18986-1-AP||Download protocol|
|IHC protocol for EGFR-Specific antibody 18986-1-AP||Download protocol|
|IP protocol for EGFR-Specific antibody 18986-1-AP||Download protocol|
|FC protocol for EGFR-Specific antibody 18986-1-AP||Download protocol|
|Click here to view our Standard Protocols|
J Exp Clin Cancer Res
Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
Ecotoxicol Environ Saf
Int J Oncol
Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway.
The exocyst functions in niche cells to promote germline stem cell differentiation by directly controlling EGFR membrane trafficking.
Int J Cancer
VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.
CAPE-pNO2 Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway.